What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

Immunovia, Inc.

Offering hope through the early detection of pancreatic cancer Early detection is invaluable. It provides hope. And it can save lives. Immunovia, Inc.

The innovators at Immunovia, Inc. have developed IMMray® PanCan-d, the first blood test dedicated to the early detection of pancreatic cancer in individuals at risk for developing familial or hereditary pancreatic ductal adenocarcinoma (PDAC). Pancreatic cancer is a low incidence disease with a high mortality rate. The survival rate for those diagnosed in late stages is tragically low at 3%, but with early detection, the survival rate jumps to 44%. The goal of the IMMray PanCan-d test is to detect pancreatic cancer at earlier stages (stage I and II), when interventions and treatments can be most effective. This test is not just an advancement in science, but a chance for individuals to have a brighter future. The science behind the IMMray® PanCan-d test is complex, but what it provides for patients at risk is simple: Hope. The IMMray® PanCan-d test is dedicated to one simple goal: early detection. With early detection, we can possibly change the outcome of this devastating disease for individuals at risk. IMMray® PanCan-d measures 9 biomarkers (mostly proteins) that, when combined in an algorithm, may indicate the presence of pancreatic cancer. It’s another powerful tool for looking for pancreatic cancer in at-risk patients, assisting with the proactive surveillance of pancreatic cancer. Imagine a world where pancreatic cancer can be caught before it has a chance to spread and cause irreparable damage. is working hard to make that world a possible reality.

Want to learn more about the IMMray® PanCan-d test? Visit immunoviainc.com. References:
American Cancer Society. Cancer Facts and Figures 2023. Brand RE, Persson J, Bratlie SO et al. Clin Transl Gastroenterol. 2022;13(3):e00468.

06/18/2023

On this Father's Day we pay tribute to the cherished memories of all the wonderful fathers who have departed. We extend comfort to those who are missing their dads.

06/16/2023

The science behind IMMray: What happens in the lab once your sample is received? 👇 🧬

Eight specific biomarkers relevant to pancreatic ductal adenocarcinoma (PDAC) are printed onto a single microarray, with 12 microarrays per slide.

Your sample is then placed on the microarray and the response to each antibody is measured using a fluorescence scanner. The CA19-9 level is measured separately on the Roche Cobas instrument. The individual measurements of each biomarker and the CA19-9 levels are then entered into an advanced algorithm to come up with a result of High-Risk Signature Present, Negative for High-Risk Signature, or Borderline.

For more information, visit our website at https://immunoviainc.com/the-immray-pancan-d-test/how-accurate-is-the-immray-pancan-d-test/

06/14/2023

We strive to make the cost of our IMMray PanCan-d early detection test affordable for every patient. The out-of-pocket cost is based on household income and number of people. Estimate your out-of-pocket cost using the chart here: https://immunoviainc.com/cost/

Call our team today at (833) 593-9522 or visit the link for more details and to read our cost-related FAQ's.

06/12/2023

Can you improve your chances of detecting pancreatic cancer early?

The answer is yes. 💜

🔑 Here are a few ways you can increase your chances of detecting it in its early stages:

1. Schedule regular check-ups. Maintaining regular physicals and health check-ups with your healthcare provider can help detect physical signs and symptoms of pancreatic cancer. Mental health is just as important as physical health, so be sure to talk with your healthcare provider about your mental health, as we know depression and anxiety may be early sign of the disease.

2. Watch for the symptoms. Some common ones are jaundice, dark urine and/or light-colored stools, abdominal and/or back pain, bloating, nausea or indigestion, newly-onset diabetes after the age of 50, and unexplained weight loss.

3. Know your risk factors. Know your family history of pancreatic cancer, and whether you fall under any of the unmodifiable or unmodifiable risk factors.

4. Consider surveillance for pancreatic cancer: Ask your doctor about the IMMray PanCan-d test to detect pancreatic cancer in its earliest stages.

💜💜💜💜💜💜💜💜💜

06/09/2023

With pancreatic cancer, treatment success is tied to the stage of cancer at diagnosis.

The stage, or classification, of cancer at the time of diagnosis plays a key role in determining the appropriate treatment for the patient. When pancreatic cancer is caught in its earliest stages, treatments have the highest chance of success.

That's why we're proud to say we've developed the first blood test dedicated to the early detection of pancreatic cancer, IMMray PanCan-d.

Visit https://immunoviainc.com/the-immray-pancan-d-test/ to learn more.

06/07/2023

When it comes to protecting your loved ones from pancreatic cancer, the best thing to do is detect it early.

IMMray PanCan-d can help detect pancreatic cancer at its earliest stages.

Ask your doctor if IMMray PanCan-d may be right for you or your loved one.
💜 https://immunoviainc.com/the-immray-pancan-d-test/

06/06/2023

What is the role of genetics in the development of pancreatic cancer?

While the exact cause of pancreatic cancer is not fully understood, some evidence suggests that specific genetic mutations, such as BRCA2 and CDKN2A (and others) are associated with an increased risk.

Additionally, a close relative with pancreatic cancer can increase your risk. 10% to 15% of people with pancreatic cancer have an immediate family member who also has/had it.

It's important to note that lifestyle choices and environmental factors can also contribute to an individual's risk.

If you think your genes may put you at an increased risk, consider IMMray PanCan-d, an early detection test for pancreatic cancer.

🧬 Learn more about the test and pancreatic cancer risk factors at https://immunoviainc.com/about-pancreatic-cancer/risk-factors-and-symptoms/

06/04/2023

Today is National Cancer Survivors Day.

A day filled with...

🎉 CELEBRATING
those who have survived

✨ INSPIRING
those recently diagnosed

✊ SUPPORTING
friends & families

📣 REACHING OUT
to the community

06/03/2023

🏃 Meet Keelin, a runner putting in the miles for pancreatic cancer.

💔 Running became Keelin's refuge and a means to reclaim her life. She experienced two profound losses: her aunt Cassie's battle with pancreatic cancer in 2009 and a pregnancy loss in 2010. Grief, depression, and anxiety consumed her during that time.

🌙 In 2013, her aunt Cassie appeared in a dream, urging her to break free from grief and embrace life. Awaking in tears, she knew it was time to heal.

👟 The next day, Keelin ran with determination, lacing up her shoes for a humble start. Despite covering only a short distance, she persisted. Running freed her from self-limiting beliefs and the weight of grief.

🏃‍♀️ Since then, Keelin has completed over a dozen half marathons, dedicating a majority to Project Purple - a nonprofit raising awareness, supporting patients, and funding pancreatic cancer research. She has also conquered multiple marathons.

🌟 Running embodies progress for Keelin—through life, grief, and the search for a cure.

💜 Recent Highlight: As a Purple Project ambassador, Keelin ran a 5k a day in May. Each day she dedicated her 5k runs and walks to those who have fought or are currently fighting pancreatic cancer. Next up she will attempt the 4x4x48 challenge to raise money for Project Purple in celebration of her upcoming 40th birthday.

➡️ Connect with Keelin at linktr.ee/keekeeontherun

06/01/2023

Today we hosted Immunovia’s new Chairman of the Board, Dr. Peter Høngaard Andersen. He toured our lab, met with the team in Marlborough, and shared his vision for the future of Immunovia. It was a pleasure getting to know Peter and hearing about his extensive experience in biotech leadership positions.

05/31/2023

Today is World No To***co Day, a day to raise awareness about the harmful effects of to***co on our health.

Did you know that to***co use is a major risk factor for pancreatic cancer? According to the American Cancer Society, smokers are two to three times more likely to develop pancreatic cancer than non-smokers. Quit today. Commit to a healthier future for yourself and your loved ones.

***coDay

05/29/2023

🎉 Happy Memorial Day! Today, we pay tribute to those who have defended our nation. It's also a time to enjoy the company of loved ones, fire up the grill, and soak up some sunshine. Let's celebrate with gratitude and a dash of summertime fun! 🌞❤️

Address

26 Forest Street
Marlborough, MA
01752

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Telephone

+18335939522

Website

https://immunoviainc.com/

Alerts

Be the first to know and let us send you an email when Immunovia, Inc. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Immunovia, Inc.:

Shortcuts

Address
Telephone
Opening Hours
Alerts
Contact The Practice
Claim ownership or report listing

Want your practice to be the top-listed Clinic in Marlborough?